Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Radiotherapy in Early Stage Follicular Lymphoma
NCT00509184Phase 2Completed
- Start
- Mar 2008
- Primary completion
- Apr 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rituximab in follicular lymphoma (FL). Primary endpoint: Progression Free Survival at 2 years. Started Mar 2008; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00509184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00509184.